Proceedings from the American Association for Cancer Research 2018 Annual Meeting
The mission of the American Association for Cancer Research (AACR) is to prevent and cure cancer through research, education, communication, and collaboration. As the largest scientific organization in the world that focuses on pioneering cancer research, it consistently and effectively stays true to this commitment, as evidenced by this year’s annual conference theme, Driving Innovative Cancer Science to Patient Care.
Oncology Times is pleased to report on the latest groundbreaking research presented at the AACR 2018 Annual Meeting, Chicago, IL.
Key opinion leaders recap the latest research from AACR 2018.
Potent & Selective TKI Shows Potential With RET-Altered Cancer Patients
Preliminary proof-of-concept data were presented from an ongoing phase I clinical trial evaluating the use of the next-generation, RET tyrosine kinase inhibitor BLU-667 at the AACR 2018 Annual Meeting.